Results 181 to 190 of about 2,144,108 (379)
Exploiting SpyTag/SpyCatcher Technology to Design New Artificial Catalytic Copper Proteins
Designing artificial metal sites in proteins is challenging due to the need to place the metal site in precise positions and to tailor the coordination environment of the metal. A modular approach based on the SpyTag/SpyCatcher technology is used to provide the Spy construct with a Cu2+/ATCUN site.
Silvia Gentili+11 more
wiley +1 more source
Risk of Breast Cancer Associated with Estrogen DNA Adduct Biomarker. [PDF]
Reding KW+10 more
europepmc +1 more source
DNA adducts as biomarkers for assessing exposure to polycyclic aromatic hydrocarbons in tissues from Xuan Wei women with high exposure to coal combustion emissions and high lung cancer mortality. [PDF]
Judy L. Mumford+4 more
openalex +1 more source
Previous studies reveal an unexpected tendency for amyloid aggregation in specific regions of the C‐terminal domain (CTD) of nucleophosmin 1 (NPM1), a nucleolar chaperone involved in acute myeloid leukemia (AML). Herein, several peptide analogs of NPM1264‐277 (amyloid core) with conservative substitutions are designed and evaluated through biophysical ...
Daniele Florio+7 more
wiley +1 more source
Cyclometalated gold(III) complexes offer a versatile platform for selective biological interactions, including cysteine arylation, redox modulation, and enzyme inhibition. This review explores their roles in anticancer, antimicrobial, and protein modification strategies, highlighting their ability to disrupt metabolic pathways, modulate aquaporins, and
Sophie R. Thomas, Riccardo Bonsignore
wiley +1 more source
A 32P-postlabeling method for detecting unstable N-7-substituted deoxyguanosine adducts in DNA. [PDF]
Dong Yu+3 more
openalex +1 more source
Linear dose-response relationship for DNA adducts in rat liver from chronic exposure to aflatoxin B1 [PDF]
Male F-344 rats were given [3H]aflatoxin B1 (AFB 1) in the drinking water at three exposure levels (0.02, 0.6, 20 μg/l, resulting in average dose levels of 2.2, 73, 2110 ng/kg per day).
Buss, P., Caviezel, M., Lutz, W.K.
core
Non‐muscle invasive bladder cancer (NMIBC) accounts for 75% of bladder cancer cases, with Bacillus Calmette‐Guérin (BCG) immunotherapy as the gold standard for high‐risk patients. BCG elicits a robust immune response but is limited by adverse effects and resistance. To enhance its efficacy, we developed a trehalose‐based conjugation strategy, tethering
Michael Grimmeisen+10 more
wiley +1 more source